About us
We are shaping the future of oncology
Our team combines expertise in oncology drug development and computational cancer biology — closing the gap between preclinical target identification and clinical translation.
Our team combines expertise in oncology drug development and computational cancer biology — closing the gap between preclinical target identification and clinical translation.
Most oncology targets fail in the clinic because preclinical models poorly reflect human disease. Gordion applies AI-driven analysis of patient-derived data to validate oncology targets before clinical development begins.
